Navigation Links
ImaRx to Report Corporate Updates and 4Q07 Financial Results
Date:3/20/2008

Live Webcast and Conference Call Scheduled for Thursday, March 27TH AT 5 PM

ET

TUCSON, Ariz., March 20 /PRNewswire-FirstCall/ -- ImaRx Therapeutics, Inc. (Nasdaq: IMRX) today announced that the Company will host a live webcast and conference call on Thursday, March 27, 2008, at 5:00 p.m. ET to discuss corporate updates and fourth quarter 2007 financial results.

The live webcast can be accessed through ImaRx's corporate website at http://www.imarx.com and will be archived on the website for 14 days following the event.

Interested parties may access the conference call by dialing (877) 407- 4018 in the U.S. and Canada or (201) 689-8471 internationally. A telephonic replay will be available through April 3, 2008 by dialing (877) 660-6853 in the U.S. and Canada or (201) 612-7415 internationally (Account Number 3055 and Conference ID 279436).

About ImaRx Therapeutics

ImaRx Therapeutics is a biopharmaceutical company commercializing and developing therapies for vascular disorders. The Company's commercialization efforts are currently focused on its FDA approved product, urokinase, for the treatment of acute massive pulmonary embolism. The Company's research and development efforts are focused on therapies for stroke and other vascular disorders using its proprietary microbubble technology.

Cautionary Statement For The Purpose Of The "Safe Harbor" Provisions Of The Private Securities Litigation Reform Act of 1995

Note: Statements made in this press release which are not historical in nature constitute forward-looking statements for purposes of the safe harbor provided by the Private Securities Litigation Reform Act
'/>"/>

SOURCE ImaRx Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
2. Bioheart, Inc. to Report Full Year 2007 Financial Results on Thursday, March 27, 2008
3. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
4. NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results
5. Vion Reports 2007 Fourth Quarter and Year-End Results
6. AutoImmune Inc. Reports 2007 Fourth Quarter and Year End Financial Results
7. Renovis Reports Fourth Quarter and Full Year 2007 Financial Results
8. Warner Chilcott Reports the Death of Its Director James Andress
9. Nile Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results
10. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
11. Unigene Restates Policy on Analyst Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2008)...secondhand smoke, an estimated ten percent of preg... developing baby to harmful cigarette byproducts f... newborns each year and poses a significant health...ind, a team of researchers has completed a global ...tter understand the fetal health risks from smokin...
(Date:12/3/2008)...stCall/ -- GlaxoSmithKline,(LSE/NYSE: GSK ) ann...ng to a,pending lawsuit in the previously announc...g shares of common stock of Genelabs Technologies,...ash without interest and less any,required withho...pletion of the tender offer that there not be,any...
(Date:12/3/2008)...Cellectricon, a leading,provider of screening sol...gning of a collaborative agreement with The Automa...f advanced automated systems for cell culture, sam...ications. Under the agreement,TAP will co-develop...ricon,s,next generation high throughput ion chann...
(Date:12/3/2008)...ogy Can Solve Pressing Food, Fuel Problems of...3 /PRNewswire/ - Dr. David Dennis, FRSC, CEO of Pe...g experts speaking at a side event at the United N...n , Poland. Dr. Dennis will outline how technology...e role it will play in solving today,s pressing is...
Breaking Biology Technology:Cutting the cord to determine babies' health risk from toxic exposure 2Cutting the cord to determine babies' health risk from toxic exposure 3Cutting the cord to determine babies' health risk from toxic exposure 4GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 2GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 3Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market. 2Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market. 3Leading Canadian Scientist to speak at UN Climate Change Conference 2
... RedPrairie Corporation has agreed to buy a global...ings Inc., extending its reach in the Asia Pacific... firms are to begin combining operations in Februa...cations; late last year RedPrairie had 650. , ,Red... and is based in Waukesha. Last week it made a sep...
...ion Center Back in the mid-1980s, encouraging eco... Wisconsin public utilities. But then Plant Sites ...business concentrations across the U.S. , ,Jim Mo...ison Gas & Electric, saw the article and mentioned...ounty had more high-tech development than the maga...
...ervice provider SupraNet plans to give $120,000 ...undation, a global disaster-relief firm run by for... and SupraNet CEO Bryan Chan said in a press relea... the unexpected number of recent disasters the cha...ricanes that hit the southeastern U.S., the Pakist...
...tores in the Madison area installed fingerprint sc...of the finger and at lower cost to the supermarke...in the supermarket,s computers that includes payme...sed provider of the biometric technology, claims t...n average 72 cents for a credit card and 36 cents ...
Other Biology Technology:Utilities help switch on economic development 2Utilities help switch on economic development 3Utilities help switch on economic development 4
(Date:12/4/2008)...up to half of a person,s body mass consisting of s...les which include those found in the limbs can r...rding to University of Illinois kinesiology and co...rch has demonstrated that the antioxidant properti...ression of certain pro-inflammatory cytokines, in ...
(Date:12/4/2008)...ord, CAA new and improved tool to monitor deforest... gotten a huge boost. The Gordon and Betty Moore F...epartment of Global Ecology with a $1.6-million gr...andsat Analysis System Lite), a new, user-friendly... and non-governmental organizations (NGOs) to map ...
(Date:12/3/2008)...N Looking at the site today, it,s easy to forget ...ersity of Wisconsin-Madison,s Franbrook Farm Resea...of the structure are gone, and acres of plants, bo...ormer basin. , Nevertheless, memories of the dam...n, UW-Madison researchers are now unearthing them....
(Date:12/3/2008)...SVILLE, Fla. The wild pea pod is big and heavy, w...of its parent plant. , And yet, like a grounded ...it manages if it has a reasonable chance of escap...t the world,s largest experimental landscape devot...s or other natural areas have discovered the pea ...
Breaking Biology News(10 mins):Vitamin E shows possible promise in easing chronic inflammation 2Vitamin E shows possible promise in easing chronic inflammation 3Tropical forest carbon monitoring gets big boost 2Researchers examine role of soil patterns in dam restoration 2Researchers examine role of soil patterns in dam restoration 3Rooted plants move mysteriously down greenways, scientists say 2Rooted plants move mysteriously down greenways, scientists say 3Hospitals Agree to Pay Fees in Exchange for More Income but Consumers in the Dark About What Theyll be Charged Under Nunez Plan 736 17th Annual Quality Conference 3A 2 Days to Lock in Discounted Rate at The Ritz Carlton 735 17th Annual Quality Conference 3A 2 Days to Lock in Discounted Rate at The Ritz Carlton 735 2University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims Confirming Need for Legislative Fix 732 1University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims Confirming Need for Legislative Fix 732 2University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims Confirming Need for Legislative Fix 732 3Plexus Systems Ranks in Top Third of the 2007 Inc 5 000 with Three Year Sales Growth of 226 25 730 1Plexus Systems Ranks in Top Third of the 2007 Inc 5 000 with Three Year Sales Growth of 226 25 730 2Plexus Systems Ranks in Top Third of the 2007 Inc 5 000 with Three Year Sales Growth of 226 25 730 3
...ldren,s Hospital of Pittsburgh have found that inc...spinal fluid may signal brain injury in infants wi...mptoms. , Infants with shaken baby syndrome (SBS)...injuries in young children ?are often misdiagnosed...infant has been shaken, the patients are too young...
...s that wipes out rice - scientists a step closer t... the globe,s most important crop but its productio...ts at the University of Exeter have shown for the ...Nature, how the world,s most destructive rice-kill...lants the fungus has to inject its proteins into t...
... at Sydney,s Garvan Institute, in collaboration wi...pt for how cancer cells can escape normal growth c...for the new generation of cancer therapies. , They..., in colon cancer. Lead researcher Associate Profe...ese large regions ?referred to as suburbs ?contain...
...onsensus among scientists, regulators, politicians...e about the possible harmful or adverse effects of...agree that these incredibly small materials can be.... Nonetheless, neighborhood stores feature produc...vel materials, from paints and cosmetics to toothp...
Other Biology News:Pittsburgh researchers discover that certain chemicals in the blood may indicate brain injury 2Cancer cells suppress large regions of DNA by a reversible process that can be tackled 2New nano-canary in the nanotoxicology coalmine: The body itself 2
Request Info
Human TIMP-1 ELISpot Development Kit from R&D Systems
Immunochemistry 1 & 2
Hucal Agx Antigen Expression Service Specificity: Hucal Agx
Biology Products: